Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 638,971
  • Shares Outstanding, K 57,721
  • Annual Sales, $ 31,500 K
  • Annual Income, $ -106,290 K
  • 60-Month Beta 1.70
  • Price/Sales 20.21
  • Price/Cash Flow N/A
  • Price/Book 181.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.53
  • Number of Estimates 2
  • High Estimate -0.50
  • Low Estimate -0.55
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -3.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.51 +21.77%
on 06/17/19
11.86 -2.36%
on 07/16/19
+2.04 (+21.38%)
since 06/14/19
3-Month
7.76 +49.23%
on 05/06/19
11.86 -2.36%
on 07/16/19
+3.27 (+39.35%)
since 04/16/19
52-Week
5.75 +101.39%
on 03/07/19
11.86 -2.36%
on 07/16/19
+2.68 (+30.11%)
since 07/16/18

Most Recent Stories

More News
Cytokinetics Inc Has Returned 51.6% Since SmarTrend Recommendation (CYTK)

SmarTrend identified an Uptrend for Cytokinetics Inc (NASDAQ:CYTK) on March 14th, 2019 at $7.30. In approximately 4 months, Cytokinetics Inc has returned 51.64% as of today's recent price of $11.07.

CYTK : 11.58 (+4.61%)
Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the completion of patient enrollment in GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart...

CYTK : 11.58 (+4.61%)
AMGN : 177.47 (+0.77%)
Shares of CYTK Up 46.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Cytokinetics Inc (NASDAQ:CYTK) on March 14th, 2019 at $7.30. In approximately 4 months, Cytokinetics Inc has returned 46.03% as of today's recent price of $10.66.

CYTK : 11.58 (+4.61%)
Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference

Two Studies Show Addition of Reldesemtiv to SMN-Directed Treatment Increases Muscle Force in Mouse Model of Spinal Muscular Atrophy

CYTK : 11.58 (+4.61%)
Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference

Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that two preclinical poster presentations on the addition of reldesemtiv to treatment with SMN upregulators (nusinersen and SMN-C1, an analogue...

CYTK : 11.58 (+4.61%)
Cytokinetics Inc Up 52.6% Since SmarTrend Uptrend Call (CYTK)

SmarTrend identified an Uptrend for Cytokinetics Inc (NASDAQ:CYTK) on March 14th, 2019 at $7.30. In approximately 3 months, Cytokinetics Inc has returned 52.60% as of today's recent price of $11.14.

CYTK : 11.58 (+4.61%)
Cytokinetics Inc Up 38.2% Since SmarTrend Uptrend Call (CYTK)

SmarTrend identified an Uptrend for Cytokinetics Inc (NASDAQ:CYTK) on March 14th, 2019 at $7.30. In approximately 3 months, Cytokinetics Inc has returned 38.22% as of today's recent price of $10.09.

CYTK : 11.58 (+4.61%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARWR, CYTK , VNDA , EPZM , PTLA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CYTK : 11.58 (+4.61%)
ARWR : 28.16 (+1.29%)
VNDA : 13.44 (-0.96%)
Relatively Good Performance Detected in Shares of Cytokinetics Inc in the Biotechnology Industry (CYTK , CTMX , FLXN , CHRS , SGMO )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CYTK : 11.58 (+4.61%)
CTMX : 11.85 (+0.51%)
FLXN : 10.91 (-4.72%)
Cytokinetics (CYTK) Reports Q1 Loss, Tops Revenue Estimates

Cytokinetics (CYTK) delivered earnings and revenue surprises of -14.89% and 36.41%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CYTK : 11.58 (+4.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CYTK with:

Business Summary

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology...

See More

Key Turning Points

2nd Resistance Point 12.30
1st Resistance Point 11.94
Last Price 11.58
1st Support Level 11.14
2nd Support Level 10.70

See More

52-Week High 11.86
Last Price 11.58
Fibonacci 61.8% 9.53
Fibonacci 50% 8.81
Fibonacci 38.2% 8.08
52-Week Low 5.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar